A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Guilherme Veiga e BOCCHI, Edimar Alcides. Idiopathic Left-Bundle Branch Block and Unexplained Symptom At Exercise: A Case Report. Arquivos Brasileiros de Cardiologia, v. 115, n. 1, p. 10-13, 2020Tradução . . Disponível em: https://doi.org/10.36660/abc.20190363. Acesso em: 01 jun. 2024.
APA
Guimarães, G. V., & Bocchi, E. A. (2020). Idiopathic Left-Bundle Branch Block and Unexplained Symptom At Exercise: A Case Report. Arquivos Brasileiros de Cardiologia, 115( 1), 10-13. doi:10.36660/abc.20190363
NLM
Guimarães GV, Bocchi EA. Idiopathic Left-Bundle Branch Block and Unexplained Symptom At Exercise: A Case Report [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 115( 1): 10-13.[citado 2024 jun. 01 ] Available from: https://doi.org/10.36660/abc.20190363
Vancouver
Guimarães GV, Bocchi EA. Idiopathic Left-Bundle Branch Block and Unexplained Symptom At Exercise: A Case Report [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 115( 1): 10-13.[citado 2024 jun. 01 ] Available from: https://doi.org/10.36660/abc.20190363
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAUGIER, Laurie et al. miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy. PLoS Neglected Tropical Diseases, v. 14, n. 12, p. 1-20 art. e0008889, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0008889. Acesso em: 01 jun. 2024.
APA
Laugier, L., Ferreira, L. R. P., Ferreira, F. M., Cabantous, S., Frade, A. F., Nunes, J. P., et al. (2020). miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy. PLoS Neglected Tropical Diseases, 14( 12), 1-20 art. e0008889. doi:10.1371/journal.pntd.0008889
NLM
Laugier L, Ferreira LRP, Ferreira FM, Cabantous S, Frade AF, Nunes JP, Ribeiro RA, Brochet P, Teixeira PC, Santos RHB, Bocchi EA, Bacal F, Cândido D da S, Maso VE, Nakaya HTI, Kalil Filho JE, Cunha Neto E, Chevillard C. miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy [Internet]. PLoS Neglected Tropical Diseases. 2020 ; 14( 12): 1-20 art. e0008889.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1371/journal.pntd.0008889
Vancouver
Laugier L, Ferreira LRP, Ferreira FM, Cabantous S, Frade AF, Nunes JP, Ribeiro RA, Brochet P, Teixeira PC, Santos RHB, Bocchi EA, Bacal F, Cândido D da S, Maso VE, Nakaya HTI, Kalil Filho JE, Cunha Neto E, Chevillard C. miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy [Internet]. PLoS Neglected Tropical Diseases. 2020 ; 14( 12): 1-20 art. e0008889.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1371/journal.pntd.0008889
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCON, Camila et al. Biventricular imaging markers to predict outcomes in non-compaction cardiomyopathy: a machine learning study. Esc heart failure, v. 7, n. 5, p. 2431-2439, 2020Tradução . . Disponível em: https://doi.org/10.1002/ehf2.12795. Acesso em: 01 jun. 2024.
APA
Rocon, C., Tabassian, M., Melo, M. D. T. de, Araujo Filho, J. A. de, Grupi, C. J., Parga Filho, J. R., et al. (2020). Biventricular imaging markers to predict outcomes in non-compaction cardiomyopathy: a machine learning study. Esc heart failure, 7( 5), 2431-2439. doi:10.1002/ehf2.12795
NLM
Rocon C, Tabassian M, Melo MDT de, Araujo Filho JA de, Grupi CJ, Parga Filho JR, Bocchi EA, D'hooge J, Salemi VMC. Biventricular imaging markers to predict outcomes in non-compaction cardiomyopathy: a machine learning study [Internet]. Esc heart failure. 2020 ; 7( 5): 2431-2439.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/ehf2.12795
Vancouver
Rocon C, Tabassian M, Melo MDT de, Araujo Filho JA de, Grupi CJ, Parga Filho JR, Bocchi EA, D'hooge J, Salemi VMC. Biventricular imaging markers to predict outcomes in non-compaction cardiomyopathy: a machine learning study [Internet]. Esc heart failure. 2020 ; 7( 5): 2431-2439.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/ehf2.12795
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Fabiana Goulart Marcondes et al. Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients. ESC Heart Failure, v. 7, p. 1744–1752, 2020Tradução . . Disponível em: https://doi.org/10.1002/ehf2.12736. Acesso em: 01 jun. 2024.
APA
Braga, F. G. M., Pereira, L. G., Pereira, S. B., Batista, G. L., Sandrigo Mangini,, Mangini, S., et al. (2020). Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients. ESC Heart Failure, 7, 1744–1752. doi:10.1002/ehf2.12736
NLM
Braga FGM, Pereira LG, Pereira SB, Batista GL, Sandrigo Mangini, Mangini S, Issa VS, Fernandes F, Bocchi EA, Ferreira SMA, Mansur AJ, Gutz IGR, Krieger JE, Pereira A da C, Bacal F. Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients [Internet]. ESC Heart Failure. 2020 ; 7 1744–1752.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/ehf2.12736
Vancouver
Braga FGM, Pereira LG, Pereira SB, Batista GL, Sandrigo Mangini, Mangini S, Issa VS, Fernandes F, Bocchi EA, Ferreira SMA, Mansur AJ, Gutz IGR, Krieger JE, Pereira A da C, Bacal F. Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients [Internet]. ESC Heart Failure. 2020 ; 7 1744–1752.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/ehf2.12736
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Alexandra Gomes dos et al. A specific IL6 polymorphic genotype modulates the risk of Trypanosoma cruzi Parasitemia While IL18, IL17A, and IL1B variant profiles and HIV infection protect against cardiomyopathy in Chagas Disease. Frontiers in Immunology, v. 11, p. 15 , 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.521409. Acesso em: 01 jun. 2024.
APA
Santos, A. G. dos, Watanabe, E. H., Ferreira, D. T., Oliveira, J. R. de, Nakanishi, É. S., Oliveira, C. da S., et al. (2020). A specific IL6 polymorphic genotype modulates the risk of Trypanosoma cruzi Parasitemia While IL18, IL17A, and IL1B variant profiles and HIV infection protect against cardiomyopathy in Chagas Disease. Frontiers in Immunology, 11, 15 . doi:10.3389/fimmu.2020.521409
NLM
Santos AG dos, Watanabe EH, Ferreira DT, Oliveira JR de, Nakanishi ÉS, Oliveira C da S, Bocchi EA, Novaes CTG, Cruz F das D da, Carvalho NB, Sato PK, Kanashiro EHY, Pontillo A, Freitas VLT de, Onuchic LF, Yasuda MAS. A specific IL6 polymorphic genotype modulates the risk of Trypanosoma cruzi Parasitemia While IL18, IL17A, and IL1B variant profiles and HIV infection protect against cardiomyopathy in Chagas Disease [Internet]. Frontiers in Immunology. 2020 ; 11 15 .[citado 2024 jun. 01 ] Available from: https://doi.org/10.3389/fimmu.2020.521409
Vancouver
Santos AG dos, Watanabe EH, Ferreira DT, Oliveira JR de, Nakanishi ÉS, Oliveira C da S, Bocchi EA, Novaes CTG, Cruz F das D da, Carvalho NB, Sato PK, Kanashiro EHY, Pontillo A, Freitas VLT de, Onuchic LF, Yasuda MAS. A specific IL6 polymorphic genotype modulates the risk of Trypanosoma cruzi Parasitemia While IL18, IL17A, and IL1B variant profiles and HIV infection protect against cardiomyopathy in Chagas Disease [Internet]. Frontiers in Immunology. 2020 ; 11 15 .[citado 2024 jun. 01 ] Available from: https://doi.org/10.3389/fimmu.2020.521409
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Brenno Rizerio e BOCCHI, Edimar Alcides. Qualidade de Vida em Insuficiência Cardíaca [Editorial]: Um Objetivo Importante no Tratamento. Arquivos Brasileiros de Cardiologia. Rio De Janeiro: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.36660/abc.20190741. Acesso em: 01 jun. 2024. , 2020
APA
Gomes, B. R., & Bocchi, E. A. (2020). Qualidade de Vida em Insuficiência Cardíaca [Editorial]: Um Objetivo Importante no Tratamento. Arquivos Brasileiros de Cardiologia. Rio De Janeiro: Faculdade de Medicina, Universidade de São Paulo. doi:10.36660/abc.20190741
NLM
Gomes BR, Bocchi EA. Qualidade de Vida em Insuficiência Cardíaca [Editorial]: Um Objetivo Importante no Tratamento [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 114( 1): 33-34.[citado 2024 jun. 01 ] Available from: https://doi.org/10.36660/abc.20190741
Vancouver
Gomes BR, Bocchi EA. Qualidade de Vida em Insuficiência Cardíaca [Editorial]: Um Objetivo Importante no Tratamento [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 114( 1): 33-34.[citado 2024 jun. 01 ] Available from: https://doi.org/10.36660/abc.20190741
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANKER, Stefan D et al. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European heart journal, v. 41, n. 22, p. 2109-2117, 2020Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehaa461. Acesso em: 01 jun. 2024.
APA
Anker, S. D., Butler, J., Khan, M. S., Abraham, W. T., Bauersachs, J., Bocchi, E. A., et al. (2020). Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European heart journal, 41( 22), 2109-2117. doi:10.1093/eurheartj/ehaa461
NLM
Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi EA, Bozkurt B, Braunwald E, Chopra VK, Cleland JG. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) [Internet]. European heart journal. 2020 ; 41( 22): 2109-2117.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/eurheartj/ehaa461
Vancouver
Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi EA, Bozkurt B, Braunwald E, Chopra VK, Cleland JG. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) [Internet]. European heart journal. 2020 ; 41( 22): 2109-2117.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/eurheartj/ehaa461
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PACKER, Milton et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. New england journal of medicine, v. 383, n. 15, p. 1413-1424, 2020Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa2022190. Acesso em: 01 jun. 2024.
APA
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., et al. (2020). Cardiovascular and renal outcomes with empagliflozin in heart failure. New england journal of medicine, 383( 15), 1413-1424. doi:10.1056/NEJMoa2022190
NLM
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Bocchi EA. Cardiovascular and renal outcomes with empagliflozin in heart failure [Internet]. New england journal of medicine. 2020 ; 383( 15): 1413-1424.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1056/NEJMoa2022190
Vancouver
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Bocchi EA. Cardiovascular and renal outcomes with empagliflozin in heart failure [Internet]. New england journal of medicine. 2020 ; 383( 15): 1413-1424.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1056/NEJMoa2022190
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VEIGA, Guilherme et al. Transplante de coração e exercício físico. Cardiologia do exercício: do atleta ao cardiopata. Tradução . Barueri: Manole, 2019. . . Acesso em: 01 jun. 2024.
APA
Veiga, G., Bacal, F., Pascoalino, L. N., & Bocchi, E. A. (2019). Transplante de coração e exercício físico. In Cardiologia do exercício: do atleta ao cardiopata. Barueri: Manole.
NLM
Veiga G, Bacal F, Pascoalino LN, Bocchi EA. Transplante de coração e exercício físico. In: Cardiologia do exercício: do atleta ao cardiopata. Barueri: Manole; 2019. [citado 2024 jun. 01 ]
Vancouver
Veiga G, Bacal F, Pascoalino LN, Bocchi EA. Transplante de coração e exercício físico. In: Cardiologia do exercício: do atleta ao cardiopata. Barueri: Manole; 2019. [citado 2024 jun. 01 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCCHI, Edimar Alcides e AVILA, Monica Samuel e AYUB-FERREIRA, Silvia Moreira. Aging, cardiotoxicity, and chemotherapy. Aging-us, v. 11, n. 2, p. 295-296, 2019Tradução . . Disponível em: https://doi.org/10.18632/aging.101776. Acesso em: 01 jun. 2024.
APA
Bocchi, E. A., Avila, M. S., & Ayub-ferreira, S. M. (2019). Aging, cardiotoxicity, and chemotherapy. Aging-us, 11( 2), 295-296. doi:10.18632/aging.101776
NLM
Bocchi EA, Avila MS, Ayub-ferreira SM. Aging, cardiotoxicity, and chemotherapy [Internet]. Aging-us. 2019 ; 11( 2): 295-296.[citado 2024 jun. 01 ] Available from: https://doi.org/10.18632/aging.101776
Vancouver
Bocchi EA, Avila MS, Ayub-ferreira SM. Aging, cardiotoxicity, and chemotherapy [Internet]. Aging-us. 2019 ; 11( 2): 295-296.[citado 2024 jun. 01 ] Available from: https://doi.org/10.18632/aging.101776
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOURA-TONELLO, Silvia Cristina Garcia de et al. Evaluation of Cardiac Autonomic Modulation Using Symbolic Dynamics After Cardiac Transplantation. Brazilian journal of cardiovascular surgery, v. 34, n. 5, p. 572-580, 2019Tradução . . Disponível em: https://doi.org/10.21470/1678-9741-2019-0236. Acesso em: 01 jun. 2024.
APA
Moura-Tonello, S. C. G. de, Carvalho, V. O., Godoy, M. F. de, Porta, A., Leal, A. M. de O., Bocchi, E. A., & Catai, A. M. (2019). Evaluation of Cardiac Autonomic Modulation Using Symbolic Dynamics After Cardiac Transplantation. Brazilian journal of cardiovascular surgery, 34( 5), 572-580. doi:10.21470/1678-9741-2019-0236
NLM
Moura-Tonello SCG de, Carvalho VO, Godoy MF de, Porta A, Leal AM de O, Bocchi EA, Catai AM. Evaluation of Cardiac Autonomic Modulation Using Symbolic Dynamics After Cardiac Transplantation [Internet]. Brazilian journal of cardiovascular surgery. 2019 ; 34( 5): 572-580.[citado 2024 jun. 01 ] Available from: https://doi.org/10.21470/1678-9741-2019-0236
Vancouver
Moura-Tonello SCG de, Carvalho VO, Godoy MF de, Porta A, Leal AM de O, Bocchi EA, Catai AM. Evaluation of Cardiac Autonomic Modulation Using Symbolic Dynamics After Cardiac Transplantation [Internet]. Brazilian journal of cardiovascular surgery. 2019 ; 34( 5): 572-580.[citado 2024 jun. 01 ] Available from: https://doi.org/10.21470/1678-9741-2019-0236
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PACKER, Milton et al. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial. European journal of heart failure, v. 21, n. 10, p. 1270-1278, 2019Tradução . . Disponível em: https://doi.org/10.1002/ejhf.1536. Acesso em: 01 jun. 2024.
APA
Packer, M., Butler, J., Filippatos, G. S., Jamal, W., Salsali, A., Schnee, J., et al. (2019). Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial. European journal of heart failure, 21( 10), 1270-1278. doi:10.1002/ejhf.1536
NLM
Packer M, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Bocchi EA. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial [Internet]. European journal of heart failure. 2019 ; 21( 10): 1270-1278.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/ejhf.1536
Vancouver
Packer M, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Bocchi EA. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial [Internet]. European journal of heart failure. 2019 ; 21( 10): 1270-1278.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/ejhf.1536
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Jefferson Luis e BOCCHI, Edimar Alcides. Letter by Vieira and Bocchi Regarding Article, ""Association Between Ambient Air Pollution and Cardiac Morpho-Functional Phenotypes [Carta]: Insights From the UK Biobank Population Imaging Study"". Circulation. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.118.038033. Acesso em: 01 jun. 2024. , 2019
APA
Vieira, J. L., & Bocchi, E. A. (2019). Letter by Vieira and Bocchi Regarding Article, ""Association Between Ambient Air Pollution and Cardiac Morpho-Functional Phenotypes [Carta]: Insights From the UK Biobank Population Imaging Study"". Circulation. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. doi:10.1161/CIRCULATIONAHA.118.038033
NLM
Vieira JL, Bocchi EA. Letter by Vieira and Bocchi Regarding Article, ""Association Between Ambient Air Pollution and Cardiac Morpho-Functional Phenotypes [Carta]: Insights From the UK Biobank Population Imaging Study"" [Internet]. Circulation. 2019 ; 139( 15): 1857-1858.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.118.038033
Vancouver
Vieira JL, Bocchi EA. Letter by Vieira and Bocchi Regarding Article, ""Association Between Ambient Air Pollution and Cardiac Morpho-Functional Phenotypes [Carta]: Insights From the UK Biobank Population Imaging Study"" [Internet]. Circulation. 2019 ; 139( 15): 1857-1858.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.118.038033
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCCHI, Edimar Alcides. The globalization of health information in different languages new frontier with JACC Portuguese [Editorial]. Journal of the american college of cardiology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.jacc.2018.11.021. Acesso em: 01 jun. 2024. , 2019
APA
Bocchi, E. A. (2019). The globalization of health information in different languages new frontier with JACC Portuguese [Editorial]. Journal of the american college of cardiology. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.jacc.2018.11.021
NLM
Bocchi EA. The globalization of health information in different languages new frontier with JACC Portuguese [Editorial] [Internet]. Journal of the american college of cardiology. 2019 ; 73( 3): 375-377.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.jacc.2018.11.021
Vancouver
Bocchi EA. The globalization of health information in different languages new frontier with JACC Portuguese [Editorial] [Internet]. Journal of the american college of cardiology. 2019 ; 73( 3): 375-377.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.jacc.2018.11.021
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCCHI, Edimar Alcides e SALEMI, Vera Maria Cury. Ivabradine for treatment of heart failure. Expert opinion on drug safety, v. 18, n. 5, p. 393-402, 2019Tradução . . Disponível em: https://doi.org/10.1080/14740338.2019.1612873. Acesso em: 01 jun. 2024.
APA
Bocchi, E. A., & Salemi, V. M. C. (2019). Ivabradine for treatment of heart failure. Expert opinion on drug safety, 18( 5), 393-402. doi:10.1080/14740338.2019.1612873
NLM
Bocchi EA, Salemi VMC. Ivabradine for treatment of heart failure [Internet]. Expert opinion on drug safety. 2019 ; 18( 5): 393-402.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1080/14740338.2019.1612873
Vancouver
Bocchi EA, Salemi VMC. Ivabradine for treatment of heart failure [Internet]. Expert opinion on drug safety. 2019 ; 18( 5): 393-402.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1080/14740338.2019.1612873
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPADARO, Andre G et al. Renal denervation in patients with heart failure secondary to Chagas' disease: a pilot randomized controlled trial. Catheterization and cardiovascular interventions, v. 94, n. 4, p. 644-650, 2019Tradução . . Disponível em: https://doi.org/10.1002/ccd.28393. Acesso em: 01 jun. 2024.
APA
Spadaro, A. G., Bocchi, E. A., Souza, G. E., Filho, A. E., Mariani Junior, J., Campos, C. M., & Lemos, P. A. (2019). Renal denervation in patients with heart failure secondary to Chagas' disease: a pilot randomized controlled trial. Catheterization and cardiovascular interventions, 94( 4), 644-650. doi:10.1002/ccd.28393
NLM
Spadaro AG, Bocchi EA, Souza GE, Filho AE, Mariani Junior J, Campos CM, Lemos PA. Renal denervation in patients with heart failure secondary to Chagas' disease: a pilot randomized controlled trial [Internet]. Catheterization and cardiovascular interventions. 2019 ; 94( 4): 644-650.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/ccd.28393
Vancouver
Spadaro AG, Bocchi EA, Souza GE, Filho AE, Mariani Junior J, Campos CM, Lemos PA. Renal denervation in patients with heart failure secondary to Chagas' disease: a pilot randomized controlled trial [Internet]. Catheterization and cardiovascular interventions. 2019 ; 94( 4): 644-650.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/ccd.28393
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARAES, Guilherme Veiga et al. Hypotensive effect of heated water-based exercise persists after 12-week cessation of training in patients with resistant hypertension. Canadian journal of cardiology, v. 34, n. 12, p. 1641-1647, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cjca.2018.09.013. Acesso em: 01 jun. 2024.
APA
Guimaraes, G. V., Drager, L. F., Cruz, L. G. de B., Castro, R. E., Ciolac, E. G., & Bocchi, E. A. (2018). Hypotensive effect of heated water-based exercise persists after 12-week cessation of training in patients with resistant hypertension. Canadian journal of cardiology, 34( 12), 1641-1647. doi:10.1016/j.cjca.2018.09.013
NLM
Guimaraes GV, Drager LF, Cruz LG de B, Castro RE, Ciolac EG, Bocchi EA. Hypotensive effect of heated water-based exercise persists after 12-week cessation of training in patients with resistant hypertension [Internet]. Canadian journal of cardiology. 2018 ; 34( 12): 1641-1647.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.cjca.2018.09.013
Vancouver
Guimaraes GV, Drager LF, Cruz LG de B, Castro RE, Ciolac EG, Bocchi EA. Hypotensive effect of heated water-based exercise persists after 12-week cessation of training in patients with resistant hypertension [Internet]. Canadian journal of cardiology. 2018 ; 34( 12): 1641-1647.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.cjca.2018.09.013
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AVILA, Monica Samuel e BOCCHI, Edimar Alcides e FERREIRA, Silvia Moreira Ayub. REPLY [Carta]: can carvedilol prevent chemotherapy-related cardiotoxicity? A dream to be balanced with tolerability. Journal of the american college of cardiology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.jacc.2018.07.003. Acesso em: 01 jun. 2024. , 2018
APA
Avila, M. S., Bocchi, E. A., & Ferreira, S. M. A. (2018). REPLY [Carta]: can carvedilol prevent chemotherapy-related cardiotoxicity? A dream to be balanced with tolerability. Journal of the american college of cardiology. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.jacc.2018.07.003
NLM
Avila MS, Bocchi EA, Ferreira SMA. REPLY [Carta]: can carvedilol prevent chemotherapy-related cardiotoxicity? A dream to be balanced with tolerability [Internet]. Journal of the american college of cardiology. 2018 ; 72( 10): 1182-1183.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.003
Vancouver
Avila MS, Bocchi EA, Ferreira SMA. REPLY [Carta]: can carvedilol prevent chemotherapy-related cardiotoxicity? A dream to be balanced with tolerability [Internet]. Journal of the american college of cardiology. 2018 ; 72( 10): 1182-1183.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.003
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCCHI, Edimar Alcides e GUIMARAES, Guilherme Veiga. Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial. Esc heart failure, v. 5, n. 3, p. 249-256, 2018Tradução . . Disponível em: https://doi.org/10.1002/ehf2.12240. Acesso em: 01 jun. 2024.
APA
Bocchi, E. A., & Guimaraes, G. V. (2018). Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial. Esc heart failure, 5( 3), 249-256. doi:10.1002/ehf2.12240
NLM
Bocchi EA, Guimaraes GV. Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial [Internet]. Esc heart failure. 2018 ; 5( 3): 249-256.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/ehf2.12240
Vancouver
Bocchi EA, Guimaraes GV. Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial [Internet]. Esc heart failure. 2018 ; 5( 3): 249-256.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/ehf2.12240
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIGUCHI, Maria de Lourdes et al. Archaea symbiont of T. cruzi infection may explain heart failure in Chagas disease. Frontiers in cellular and infection microbiology, v. 8, 2018Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2018.00412. Acesso em: 01 jun. 2024.
APA
Higuchi, M. de L., Kawakami, J. T., Ikegami, R. N., Reis, M. M., Pereira, J. de J., Ianni, B. M., et al. (2018). Archaea symbiont of T. cruzi infection may explain heart failure in Chagas disease. Frontiers in cellular and infection microbiology, 8. doi:10.3389/fcimb.2018.00412
NLM
Higuchi M de L, Kawakami JT, Ikegami RN, Reis MM, Pereira J de J, Ianni BM, Buck P, Oliveira LM da S, Santos MHH, Hajjar LA, Bocchi EA. Archaea symbiont of T. cruzi infection may explain heart failure in Chagas disease [Internet]. Frontiers in cellular and infection microbiology. 2018 ; 8[citado 2024 jun. 01 ] Available from: https://doi.org/10.3389/fcimb.2018.00412
Vancouver
Higuchi M de L, Kawakami JT, Ikegami RN, Reis MM, Pereira J de J, Ianni BM, Buck P, Oliveira LM da S, Santos MHH, Hajjar LA, Bocchi EA. Archaea symbiont of T. cruzi infection may explain heart failure in Chagas disease [Internet]. Frontiers in cellular and infection microbiology. 2018 ; 8[citado 2024 jun. 01 ] Available from: https://doi.org/10.3389/fcimb.2018.00412